2Decisions
2Patient groups
Added benefit by patient group
Decisions, newest first
Each decision lists only the patient groups coded with this disease.
MinorHint
Erwachsene mit Morbus Pompe (Mangel an saurer α-Glucosidase [GAA]) der späten Verlaufsform
Active substance
Cipaglucosidase alfa
Appropriate comparator therapy
Alglucosidase alfa
Non-quantifiableHint
Kinder, Jugendliche und Erwachsene mit primärer Hyperoxalurie Typ 1 (PH1)
Active substance
Lumasiran
Appropriate comparator therapy
N/A
ICD codes
Diagnoses
- Primäre Hyperoxalurie Typ 1
Data status: 2026-10-29